首页> 外文期刊>BMC Cancer >Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study
【24h】

Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study

机译:输尿管镜和ul激光治疗上尿路尿路上皮癌:回顾性单中心研究

获取原文
           

摘要

Treatment with the combination of ureteroscopy and thulium laser ablation may provide an alternative to radical nephroureterectomy (RNU) for patients with upper tract urothelial carcinoma (UTUC). The purpose of this study was to investigate the efficacy and safety of this technique. We performed a retrospective review of the data for patients who were treated surgically for upper tract urothelial carcinoma in a single center. It included 32 patients treated by endoscopic thulium laser resection and 107 patients treated by radical nephroureterectomy (RNU). We compared the data of patient sex, age at diagnosis, location of carcinoma, length of hospitalization, tumor site, size, grade, recurrence, preoperative creatinine and postoperative creatinine in two groups. Patients were examined by ureteroscopy every 3?months during the first year after surgery, then every 6?months each year. All 32 patients were treated successfully, among which 6 were operated by a flexible ureteroscope. The average tumor size was 13?±?7?mm in diameter. The tumor was rated as low grade in 27 patients and high grade in 5 patients. Ureteral stricture developed in 4 patients 3?months later after surgery, but the stricture was succesfully treated through endoscopic dilation. Seven patients had tumor recurrence, 3 of which underwent nephroureterectomy during the follow-up. Postoperative creatinine levels (umol/L) were respectively 89?±?7.5 in laser group and 123?±?15.4 in RNU group (p?
机译:输尿管镜和th激光消融相结合的治疗可能为上尿路尿路上皮癌(UTUC)患者提供根治性肾切除术(RNU)的替代方法。这项研究的目的是调查这项技术的有效性和安全性。我们对单个中心接受上尿路尿路上皮癌手术治疗的患者的数据进行了回顾性回顾。其中包括32例经内镜th激光切除术治疗的患者和107例经根治性肾切除术(RNU)治疗的患者。我们比较了两组患者的性别,诊断年龄,癌的位置,住院时间,肿瘤部位,大小,等级,复发,术前肌酐和术后肌酐的数据。术后第一年每3个月进行输尿管镜检查,然后每年每6个月进行检查。全部32例患者均获成功治疗,其中6例采用输尿管镜进行手术。平均肿瘤大小为直径13±±7μm。该肿瘤在27例中被定为低度,在5例中被定为高度。术后3个月后有4例患者发生输尿管狭窄,但经内镜扩张成功治疗了狭窄。 7例肿瘤复发,其中3例在随访期间接受了肾结石切除术。激光组术后肌酐水平(umol / L)分别为89±±7.5,RNU组为123±±15.4(p <0.01)。住院时间分别为3.6±±1.9天和8.6±±2.4天(p <0.01)。 laser激光组和RNU组的局部或膀胱复发率分别为21.9%和13.1%(p <0.01)。 laser激光组与较少的肾功能丧失,较短的住院时间和较高的肿瘤复发率相关。 selected激光疗法与输尿管镜治疗相结合可被视为某些UTUC病例的可接受治疗。终生密集监视是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号